Atovaquone Patent Expiration
Atovaquone is Used for treating Pneumocystis carinii infections. It was first introduced by Glaxosmithkline Llc
Atovaquone Patents
Given below is the list of patents protecting Atovaquone, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Mepron |
US6649659 (Pediatric) | Atovaquone pharmaceutical compositions |
Jan 10, 2017
(Expired) | Glaxosmithkline Llc |
| Mepron | US6649659 | Atovaquone pharmaceutical compositions |
Jul 10, 2016
(Expired) | Glaxosmithkline Llc |
Atovaquone's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List